Genomic biomarkers and cellular pathways of ischemic stroke by RNA gene expression profiling

T. L. Barr, Y. Conley, J. Ding, A. Dillman, S. Warach, A. Singleton, M. Matarin

Research output: Contribution to journalArticle

100 Citations (Scopus)

Abstract

Objective: The objective of this study was to provide insight into the molecular mechanisms of acute ischemic cerebrovascular syndrome (AICS) through gene expression profiling and pathway analysis. Methods: Peripheral whole blood samples were collected from 39 MRI-diagnosed patients with AICS and 25 nonstroke control subjects ≥18 years of age. Total RNA was extracted from whole blood stabilized in Paxgene RNA tubes, amplified, and hybridized to Illumina HumanRef-8v2 bead chips. Gene expression was compared in a univariate manner between stroke patients and control subjects using t test in GeneSpring. The significant genes were tested in a logistic regression model controlling for age, hypertension, and dyslipidemia. Inflation of type 1 error was corrected by Bonferroni and Ingenuity Systems Pathway analysis was performed. Validation was performed by QRT-PCR using Taqman gene expression assays. Results: A 9-gene profile was identified in the whole blood of ischemic stroke patients using gene expression profiling. Five of these 9 genes were identified in a previously published expression profiling study of stroke and are therefore likely biomarkers of stroke. Pathway analysis revealed toll-like receptor signaling as a highly significant canonical pathway present in the peripheral whole blood of patients with AICS. Conclusions: Our study highlights the relevance of the innate immune system through toll-like receptor signaling as a mediator of response to ischemic stroke and supports the claim that gene expression profiling can be used to identify biomarkers of ischemic stroke. Further studies are needed to validate and refine these biomarkers for their diagnostic potential.

Original languageEnglish (US)
Pages (from-to)1009-1014
Number of pages6
JournalNeurology
Volume75
Issue number11
DOIs
StatePublished - Sep 14 2010

Fingerprint

Gene Expression Profiling
Biomarkers
Stroke
RNA
Toll-Like Receptors
Logistic Models
Genes
Gene Expression
Economic Inflation
Dyslipidemias
Immune System
Hypertension
Polymerase Chain Reaction

ASJC Scopus subject areas

  • Clinical Neurology
  • Medicine(all)

Cite this

Barr, T. L., Conley, Y., Ding, J., Dillman, A., Warach, S., Singleton, A., & Matarin, M. (2010). Genomic biomarkers and cellular pathways of ischemic stroke by RNA gene expression profiling. Neurology, 75(11), 1009-1014. https://doi.org/10.1212/WNL.0b013e3181f2b37f

Genomic biomarkers and cellular pathways of ischemic stroke by RNA gene expression profiling. / Barr, T. L.; Conley, Y.; Ding, J.; Dillman, A.; Warach, S.; Singleton, A.; Matarin, M.

In: Neurology, Vol. 75, No. 11, 14.09.2010, p. 1009-1014.

Research output: Contribution to journalArticle

Barr, TL, Conley, Y, Ding, J, Dillman, A, Warach, S, Singleton, A & Matarin, M 2010, 'Genomic biomarkers and cellular pathways of ischemic stroke by RNA gene expression profiling', Neurology, vol. 75, no. 11, pp. 1009-1014. https://doi.org/10.1212/WNL.0b013e3181f2b37f
Barr TL, Conley Y, Ding J, Dillman A, Warach S, Singleton A et al. Genomic biomarkers and cellular pathways of ischemic stroke by RNA gene expression profiling. Neurology. 2010 Sep 14;75(11):1009-1014. https://doi.org/10.1212/WNL.0b013e3181f2b37f
Barr, T. L. ; Conley, Y. ; Ding, J. ; Dillman, A. ; Warach, S. ; Singleton, A. ; Matarin, M. / Genomic biomarkers and cellular pathways of ischemic stroke by RNA gene expression profiling. In: Neurology. 2010 ; Vol. 75, No. 11. pp. 1009-1014.
@article{af28f7c34f5f493d8713e95b23fc1d1a,
title = "Genomic biomarkers and cellular pathways of ischemic stroke by RNA gene expression profiling",
abstract = "Objective: The objective of this study was to provide insight into the molecular mechanisms of acute ischemic cerebrovascular syndrome (AICS) through gene expression profiling and pathway analysis. Methods: Peripheral whole blood samples were collected from 39 MRI-diagnosed patients with AICS and 25 nonstroke control subjects ≥18 years of age. Total RNA was extracted from whole blood stabilized in Paxgene RNA tubes, amplified, and hybridized to Illumina HumanRef-8v2 bead chips. Gene expression was compared in a univariate manner between stroke patients and control subjects using t test in GeneSpring. The significant genes were tested in a logistic regression model controlling for age, hypertension, and dyslipidemia. Inflation of type 1 error was corrected by Bonferroni and Ingenuity Systems Pathway analysis was performed. Validation was performed by QRT-PCR using Taqman gene expression assays. Results: A 9-gene profile was identified in the whole blood of ischemic stroke patients using gene expression profiling. Five of these 9 genes were identified in a previously published expression profiling study of stroke and are therefore likely biomarkers of stroke. Pathway analysis revealed toll-like receptor signaling as a highly significant canonical pathway present in the peripheral whole blood of patients with AICS. Conclusions: Our study highlights the relevance of the innate immune system through toll-like receptor signaling as a mediator of response to ischemic stroke and supports the claim that gene expression profiling can be used to identify biomarkers of ischemic stroke. Further studies are needed to validate and refine these biomarkers for their diagnostic potential.",
author = "Barr, {T. L.} and Y. Conley and J. Ding and A. Dillman and S. Warach and A. Singleton and M. Matarin",
year = "2010",
month = "9",
day = "14",
doi = "10.1212/WNL.0b013e3181f2b37f",
language = "English (US)",
volume = "75",
pages = "1009--1014",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - Genomic biomarkers and cellular pathways of ischemic stroke by RNA gene expression profiling

AU - Barr, T. L.

AU - Conley, Y.

AU - Ding, J.

AU - Dillman, A.

AU - Warach, S.

AU - Singleton, A.

AU - Matarin, M.

PY - 2010/9/14

Y1 - 2010/9/14

N2 - Objective: The objective of this study was to provide insight into the molecular mechanisms of acute ischemic cerebrovascular syndrome (AICS) through gene expression profiling and pathway analysis. Methods: Peripheral whole blood samples were collected from 39 MRI-diagnosed patients with AICS and 25 nonstroke control subjects ≥18 years of age. Total RNA was extracted from whole blood stabilized in Paxgene RNA tubes, amplified, and hybridized to Illumina HumanRef-8v2 bead chips. Gene expression was compared in a univariate manner between stroke patients and control subjects using t test in GeneSpring. The significant genes were tested in a logistic regression model controlling for age, hypertension, and dyslipidemia. Inflation of type 1 error was corrected by Bonferroni and Ingenuity Systems Pathway analysis was performed. Validation was performed by QRT-PCR using Taqman gene expression assays. Results: A 9-gene profile was identified in the whole blood of ischemic stroke patients using gene expression profiling. Five of these 9 genes were identified in a previously published expression profiling study of stroke and are therefore likely biomarkers of stroke. Pathway analysis revealed toll-like receptor signaling as a highly significant canonical pathway present in the peripheral whole blood of patients with AICS. Conclusions: Our study highlights the relevance of the innate immune system through toll-like receptor signaling as a mediator of response to ischemic stroke and supports the claim that gene expression profiling can be used to identify biomarkers of ischemic stroke. Further studies are needed to validate and refine these biomarkers for their diagnostic potential.

AB - Objective: The objective of this study was to provide insight into the molecular mechanisms of acute ischemic cerebrovascular syndrome (AICS) through gene expression profiling and pathway analysis. Methods: Peripheral whole blood samples were collected from 39 MRI-diagnosed patients with AICS and 25 nonstroke control subjects ≥18 years of age. Total RNA was extracted from whole blood stabilized in Paxgene RNA tubes, amplified, and hybridized to Illumina HumanRef-8v2 bead chips. Gene expression was compared in a univariate manner between stroke patients and control subjects using t test in GeneSpring. The significant genes were tested in a logistic regression model controlling for age, hypertension, and dyslipidemia. Inflation of type 1 error was corrected by Bonferroni and Ingenuity Systems Pathway analysis was performed. Validation was performed by QRT-PCR using Taqman gene expression assays. Results: A 9-gene profile was identified in the whole blood of ischemic stroke patients using gene expression profiling. Five of these 9 genes were identified in a previously published expression profiling study of stroke and are therefore likely biomarkers of stroke. Pathway analysis revealed toll-like receptor signaling as a highly significant canonical pathway present in the peripheral whole blood of patients with AICS. Conclusions: Our study highlights the relevance of the innate immune system through toll-like receptor signaling as a mediator of response to ischemic stroke and supports the claim that gene expression profiling can be used to identify biomarkers of ischemic stroke. Further studies are needed to validate and refine these biomarkers for their diagnostic potential.

UR - http://www.scopus.com/inward/record.url?scp=77957283824&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957283824&partnerID=8YFLogxK

U2 - 10.1212/WNL.0b013e3181f2b37f

DO - 10.1212/WNL.0b013e3181f2b37f

M3 - Article

C2 - 20837969

AN - SCOPUS:77957283824

VL - 75

SP - 1009

EP - 1014

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 11

ER -